In focus
Latest feed
India’s Pharma Q1 FY27 Outlook: Domestic Boost Offsets U.S. Earnings Squeeze
The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s
The Pharmaceutical Frontier: Biosimilars on the Rise
A Game Changer for Canadians? Dr. Reddy's Unveils Generic Semaglutide Injection
